FRANKLIN M. BERGER

Corporate Board Profile

Tech Score: 0/100

Lineage Cell Therapeutics, Inc.

Filing Date	Source Excerpt
2013-10-07	Mr. Berger is a consultant to biotechnology industry participants, including major biopharmaceutical firms, mid-capitalization biotechnology companies, specialist asset managers and venture capital companies, providing business development, strategic advisory, financing, partnering, and royalty acquisition advice. Mr. Berger is also a biotechnology industry analyst with over 25 years of experience in capital markets and financial analysis.

Filing Date

Source Excerpt

2013-10-07

Mr. Berger is a consultant to biotechnology industry participants, including major biopharmaceutical firms, mid-capitalization biotechnology companies, specialist asset managers and venture capital companies, providing business development, strategic advisory, financing, partnering, and royalty acquisition advice. Mr. Berger is also a biotechnology industry analyst with over 25 years of experience in capital markets and financial analysis.

Data sourced from SEC filings. Last updated: 2025-08-30